29 April 2022

Publication of Annual Report and Financial Statements for the Year ended 31 December 2021

29 March 2022

Scheme of Arrangement Information Sheet

28 March 2022

Proposed Transaction with Eagle Pharmaceuticals, Inc. (Part 1 of 2)

28 March 2022

Proposed Transaction with Eagle Pharmaceuticals, Inc (Part 2 of 2)

23 March 2022

Acacia Pharma Announces Chief Financial Officer Gary Gemignani is to Leave the Company

Post Graduate Assembly in Anesthesiology (PGA)

New York, NY
10-14 December 2021

13 December 2021

Acacia Pharma Announces Successful Completion of BARHEMSYS® Post-approval Requirement Study in Patients with Severe Renal Impairment 

13 December 2021

Acacia Pharma meldt de succesvolle voltooiing van de studie met BARHEMSYS® bij patiënten met ernstige nierinsufficiëntie, die was vereist bij de toekenning van de marktautorisatie

American Society of Hospital Pharmacists (ASHP)

Orlando, FL
5-9 December 2021

American College of Gastroenterology (ACG)

Las Vegas, NV
22-27 October 2021

American College of Chest Physicians (CHEST)

Orlando, FL
17-20 October 2021

American Society of Anesthesiologists (ASA)

San Diego, CA
8-12 October 2021

American Association of Oral and Maxillofacial Surgeons (AAOMS)

Nashville, TN
27 September - 2 October 2021

American Society of Enhanced Recovery (ASER)

Virtual
29 September - 1 October 2021

KOL Webinar: Hospital User Experience with Barhemsys® and Byfavo®

30 September 2021 (18:00 CEST / 12:00 EDT)

Interested parties are requested to register in advance for the webcast by clicking here. For those who are unable to listen at this time, a replay of the call will be available on the Company’s website and by clicking here.

A live Q&A session will follow the presentations and participants can submit questions during the session via questions@lifesciadvisors.com.

30 September 2021

Tussentijdse resultaten voor de periode van zes maanden eindigend op 30 juni 2021 – Blijvend sterke opname van Barhemsys en Byfavo tot ziekenhuisformularia in laceringsfase

30 September 2021

Interim Results for the Six Months ended 30 June 2021 - Barhemsys® and Byfavo® Launches Continue to Achieve Strong Hospital Formulary Adoption

29 September 2021

Acacia Pharma Announces Submission and Validation of Marketing Authorization Application for BARHEMSYS® (amisulpride injection) in Major European Markets

16 September 2021

Acacia Pharma Announces Initiation of Pivotal Study of Byfavo® in Pediatric Procedural Sedation

16 September 2021

Acacia Pharma kondigt de start aan van een cruciale studie met  Byfavo® voor sedatie van pediatrische patiënten die een medische procedure ondergaan

Society of American Gastrointestinal & Endoscopic Surgeons (SAGES)

Las Vegas, NV
31 August - 3 September 2021

02 September 2021

Acacia Pharma to Host Webinar with Key Opinion Leaders to Discuss the Hospital User Experience with Barhemsys® and Byfavo®

02 September 2021

Acacia Pharma organiseert een webinar met belangrijke opinieleiders waarin de ervaring van hospitaalgebruikers met Barhemsys® and Byfavo® wordt besproken

American Association of Bronchoscopy and Interventional Pulmonology (AABIP)

Baltimore, MD
26-28 August 2021

American Association of Nurse Anesthestists (AANA)

Austin, TX
13-17 August 2021